rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Stepan Company

SCL · NYSE

MaterialsChemicalsLeading

SCL stood above a rising 150-day average in 30 of the last 52 weekly readings, including each of the last 22 weeks. It is 10.2% above that average now. Chemicals: 25% of its 85 stocks in an uptrend (−1 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
22 in a row
Industry in uptrend
25% -1 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
3
Institutions holding
208 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 30 of 52 weeks.

20 Apr – 19 Oct
18%38%58%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has held steady. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$482K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 0, Senate 0, executive 3; 1 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k30 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k4 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k26 Feb 2026filed 14 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders208+5 on the quarter
New · exited32 · 27
Reported value$1.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20263,458,328$192.7M+147,288+4.4%
HighTower Advisors, LLCreduced · filed 5 Aug 20261,589,877$88.6M-1880.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20261,381,590$77.0M+22,737+1.7%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,125,025$62.7M+7,995+0.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026949,949$52.9M+7,958+0.8%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026948,532$52.9M+216,411+29.6%
DEPRINCE RACE & ZOLLO INCreduced · filed 20 Aug 2026936,608$52.2M-10,844−1.1%
STATE STREET CORPreduced · filed 7 Aug 2026888,716$49.5M-13,948−1.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026565,294$31.5M+35,734+6.7%
AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026433,582$24.2M+40,313+10.3%
31 Mar 2023 – 30 Jun 2026
159183206Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Shawn G. Lisle Company insiderVP GC & Secretary · last 26 Aug 20260 · 0
Ruben Dario Velasquez Company insiderSVP & Chief Financial Officer · last 10 Aug 20260 · 0
Robin Joseph Weitkamp Company insiderVP and GM Surfactants-INT · last 11 May 20260 · 0
Corning F. Painter Company insiderDirector · last 8 May 20260 · 0
F. Quinn Stepan Jr. Company insiderDirector · last 8 May 20260 · 46
Jan Stern Reed Company insiderDirector · last 8 May 20261 · 0
Joaquin Delgado Company insiderDirector · last 8 May 20260 · 0
Lorinda Burgess Company insiderDirector · last 8 May 20260 · 0
Randall S. Dearth Company insiderDirector · last 8 May 20260 · 1
Susan Lewis Company insiderDirector · last 8 May 20261 · 0
Robert Joseph Haire Company insiderEVP, Supply Chain · last 1 May 20260 · 0
Afonso Adriano Jose Galimberti Company insiderVP and GM Surfactants NA · last 13 Apr 20260 · 0

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+16%
MEOH MethanexLeading+11%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202511.6%
Operating profit marginFY 2025 · to 31 Dec 20253.4%
Free cash flow marginFY 2025 · to 31 Dec 20251.1%
Return on capital employedFY 2025 · to 31 Dec 20254.6%
Cash conversionFY 2025 · to 31 Dec 2025315%
Debt to equityFY 2025 · to 31 Dec 20250.73×
Interest coverFY 2025 · to 31 Dec 20252.55×
Research spendFY 2025 · to 31 Dec 20251.5%
Share count trendFY 2025 · to 31 Jan 2026-1.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$132.7M
Free cash flowFY 2025 · to 31 Dec 2025$25.4M

Analyst forecasts

No analyst forecasts yet.